Also from this source

You just read:

Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients

News provided by

Daiichi Sankyo, Inc. , Plexxikon Inc.

Jul 29, 2015, 05:00 ET